Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$300,741,013
+$17,858,751 QoQ
Shares Held
2,340,397
-0.5% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#100
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $1,673,064,906 across 14 Drug Manufacturers - General names. MRK ranks #3 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
396,540 | $475,622,010 | |
| 2 | JNJ |
Johnson & Johnson
|
1,458,722 | $370,471,625 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
2,340,397 | $300,741,013 | |
| 4 | AMGN |
Amgen Inc
|
494,025 | $178,896,331 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
876,893 | $110,786,660 | |
| 6 | ABBV |
AbbVie Inc.
|
391,576 | $98,536,182 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,147,117 | $66,096,880 | |
| 8 | AZN |
Astrazeneca PLC
|
282,337 | $53,536,741 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,741,013 | 2,340,397 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $282,882,262 | 2,351,669 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $253,402,081 | 2,407,392 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $199,725,366 | 2,379,666 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $175,841,431 | 2,221,342 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $126,758,025 | 1,467,661 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $153,332,400 | 1,541,339 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $208,649,918 | 1,837,354 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $219,783,003 | 1,775,307 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $226,113,476 | 1,713,630 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $194,378,187 | 1,782,959 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $200,502,535 | 1,947,572 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $241,989,790 | 2,097,147 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $225,161,346 | 2,116,377 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $257,788,994 | 2,323,470 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $218,301,366 | 2,534,851 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $189,549,174 | 2,079,074 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $168,758,715 | 2,056,779 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $181,939,985 | 2,373,956 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $154,153,282 | 2,052,367 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $155,868,498 | 2,004,224 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $154,789,862 | 2,007,910 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $157,047,829 | 1,919,901 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $172,356,988 | 2,077,841 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $163,188,407 | 2,110,285 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $157,546,893 | 2,047,660 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||